Tarrytown, NY: Regeneron Pharmaceuticals Inc
If youre taking Ozempic, Wegovy, Mounjaro, Zepbound, or Saxenda, youre not alone
For patients on Medicare and Medicaid, those government programs generally will not cover weight-loss drugs, a longstanding statutory prohibition that physicians believe must be revisited if the US is to take advantage of these treatments
It is available in two forms: insoluble and soluble
The IRS permits these tax-advantaged accounts to cover compounded medications that treat medically recognized conditions, and obesity with a BMI of 30 or higher qualifies under current medical guidelines
Focus: Managing side effects, establishing eating patterns, surviving the difficult middle weeks